NYSE:LLYPharmaceuticals
Eli Lilly Expands LillyDirect Ecosystem For Obesity Care And Investor Watchpoints
Eli Lilly (NYSE:LLY) is expanding LillyDirect by partnering with Weight Watchers Med+ to offer integrated weight management support.
The company is also adding direct care services from Sesame to the platform, giving patients more access points for obesity and diabetes care.
These partnerships come as demand for GLP-1 medications grows and patients look for more comprehensive support beyond prescriptions.
Eli Lilly operates as a global pharmaceutical company with a growing focus on obesity...